Pharmanutra Logo

Pharmanutra

Develops and distributes nutritional supplements and medical devices based on research.

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA

Description

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 10:33
CS_Disponibilità Relazione Semestrale 2025 || Availability Half Year financial …
Italian 269.4 KB
2025-09-08 17:55
PHN: The Board of Directors approved the results as of 30 June 2025
English 443.8 KB
2025-09-08 17:55
PHN: il Consiglio di Amministrazione ha approvato i risultati al 30 giugno 2025
Italian 370.0 KB
2025-08-04 18:05
PR PHARMANUTRA SPA - Sidevit B12 sales
English 465.8 KB
2025-08-04 18:04
CS PHARMANUTRA SPA - Vendite Sidevit B12
Italian 259.1 KB
2025-06-03 08:00
Pharmanutra: Lancio ApportAL Boost
Italian 189.4 KB
2025-06-03 08:00
Pharmanutra: Launch of ApportAL Boost
English 241.0 KB
2025-05-27 10:47
MIDCAP Road Show - Paris
English 3.4 MB
2025-05-15 15:26
Statuto sociale aggiornato
Italian 295.1 KB
2025-05-15 15:25
Verbale Assemblea ordinaria e straordinaria degli Azionisti del 26 aprile 2025
Italian 9.4 MB
2025-05-15 15:23
Pharmanutra: Avviso deposito verbale Assemblea e Statuto aggiornato_Filing of m…
Italian 172.3 KB
2025-05-14 11:46
Interim Management report as at March 31st, 2025
English 1.7 MB
2025-05-14 11:45
Resoconto Intermedio di gestione al 31 Marzo 2025
Italian 1.4 MB
2025-05-14 11:44
Avviso deposito Rendiconto Intermedio di gestione al 31 marzo 2025 || Notice of…
Italian 177.0 KB
2025-05-12 17:30
Pharmanutra: CdA approva il Resoconto intermedio di gestione al 31 marzo 2025
Italian 282.7 KB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmanutra

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.